Table 1.
The relationship between serum tumor marker levels and clinicopathological features in patients with IBD and rectal cancer ().
| Clinicopathological features | n | CA242 (U/ml) | t | P | CA724 (U/ml) | t | P | TPA (U/L) | t | P |
|---|---|---|---|---|---|---|---|---|---|---|
| Gender | 0.738 | 0.463 | 0.607 | 0.546 | 1.206 | 0.233 | ||||
| Male | 36 | 16.20 ± 2.11 | 24.89 ± 2.14 | 162.95 ± 10.10 | ||||||
| Female | 24 | 15.78 ± 2.23 | 24.55 ± 2.10 | 159.68 ± 10.58 | ||||||
| Age (years old) | 1.081 | 0.284 | 0.530 | 0.598 | 0.910 | 0.367 | ||||
| ≥50 years old | 34 | 16.23 ± 2.10 | 24.80 ± 2.13 | 161.55 ± 11.10 | ||||||
| <50 years old | 26 | 15.64 ± 2.09 | 24.50 ± 2.23 | 158.78 ± 12.41 | ||||||
| Tumor size (cm) | 11.888 | <0.001 | 0.786 | 0.435 | 0.577 | 0.566 | ||||
| ≥5 | 32 | 18.44 ± 1.98 | 24.99 ± 2.10 | 161.25 ± 10.45 | ||||||
| <5 | 28 | 12.76 ± 1.68 | 24.56 ± 2.13 | 159.68 ± 10.58 | ||||||
| Histological grades | 3.146 | 0.012 | 6.223 | 0.012 | 2.653 | 0.023 | ||||
| G1 | 15 | 13.10 ± 2.11 | 18.41 ± 2.23 | 149.23 ± 10.68 | ||||||
| G2 | 40 | 15.21 ± 2.13 | 24.55 ± 2.23 | 156.98 ± 12.14 | ||||||
| G3 | 5 | 17.42 ± 2.10 | 26.85 ± 2.14 | 169.79 ± 12.65 | ||||||
| Growth modes | 13.029 | <0.001 | 5.157 | 0.040 | 2.660 | 0.096 | ||||
| Ulcerative | 30 | 14.23 ± 1.25 | 22.14 ± 2.65 | 156.21 ± 12.58 | ||||||
| Invasive | 25 | 20.12 ± 1.10 | 26.98 ± 2.14 | 168.98 ± 12.65 | ||||||
| Contracted | 5 | 11.10 ± 1.54 | 20.15 ± 2.10 | 149.65 ± 11.65 | ||||||
| T stages | 3.532 | 0.001 | 10.081 | <0.001 | 4.392 | <0.001 | ||||
| T1−2 | 20 | 14.26 ± 1.25 | 22.10 ± 2.12 | 155.26 ± 11.54 | ||||||
| T3−4 | 40 | 15.65 ± 1.52 | 28.14 ± 2.22 | 169.23 ± 11.65 | ||||||
| N stages | 0.783 | 0.437 | 8.461 | <0.001 | 0.955 | 0.344 | ||||
| N0 | 32 | 5.89 ± 1.23 | 10.63 ± 2.11 | 159.65 ± 12.10 | ||||||
| N1−2 | 28 | 15.68 ± 1.44 | 21.95 ± 2.13 | 162.58 ± 11.58 | ||||||
| M stages | 1.208 | 0.232 | 8.866 | <0.001 | 3.048 | 0.004 | ||||
| M0 | 52 | 15.55 ± 1.23 | 21.23 ± 2.20 | 154.98 ± 12.50 | ||||||
| M1 | 8 | 16.23 ± 2.68 | 28.65 ± 2.23 | 169.21 ± 10.65 | ||||||
| TNM stages | 3.901 | <0.001 | 9.669 | <0.001 | <0.001 | |||||
| I-II | 30 | 14.59 ± 1.26 | 22.65 ± 2.14 | 153.65 ± 12.10 | ||||||
| III-IV | 30 | 16.68 ± 2.65 | 27.98 ± 2.13 | 166.54 ± 11.58 | ||||||
| Perineural invasion | 0.153 | 0.879 | 0.687 | 0.495 | 0.601 | 0.550 | ||||
| Y | 5 | 15.85 ± 2.12 | 24.30 ± 2.12 | 158.65 ± 12.65 | ||||||
| N | 55 | 16.00 ± 2.10 | 24.98 ± 2.12 | 162.20 ± 12.65 | ||||||
| Vascular invasion | 0.287 | 0.775 | 1.426 | 0.159 | 0.477 | 0.656 | ||||
| Y | 6 | 15.75 ± 2.16 | 24.23 ± 1.59 | 159.65 ± 13.26 | ||||||
| N | 54 | 16.01 ± 2.10 | 24.99 ± 1.20 | 162.20 ± 13.25 |